Neogen SEC Filings
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
11.85+0.14 (+1.20%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Neogen filing overview
This page lists 2 recent SEC filings by Neogen (NEOG), including 1 4, 1 10-Q. The most recent quarterly report (10-Q) was filed on Oct 7, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
NEOG SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 7, 2026 | 10-Q | Quarterly report | View on EDGAR |